Is stavudine triphosphate a natural metabolite of zidovudine? [3]

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 8, 2006, Pages 2899-

  Benech, Henri ^a   Becher, François ^a   Pruvost, Alain ^a   Grassi, Jacques J ^a  

^a DIF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE TRIPHOSPHATE; UNCLASSIFIED DRUG; ZIDOVUDINE;

CONTAMINATION; DRUG DETERMINATION; DRUG TRANSFORMATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

ANTI-HIV AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HIV INFECTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; STAVUDINE; ZIDOVUDINE;

EID: 33746902397     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00412-06     Document Type: Letter

References (10)

1. Becher, F., A. G. Pruvost, D. D. Schlemmer, C. A. Creminon, C. M. Goujard, J. F. Delfraissy, H. C. Benech, and J. J. Grassi. 2003. Significant levels of intracellular stavudine triphosphate are found in HIV-infected zidovudine-treated patients. AIDS 17:555-561.
2. Becher, F., A. Pruvost, J. Gale, P. Couerbe, C. Goujard, V. Beutet, E. Ezan, J. Grassi, and H. Benech. 2003. A strategy for liquid chromatography/ tandem mass spectrometric assays of intracellular drugs: application to the validation of the triphosphorylated anabolite of antiretrovirals in peripheral blood mononuclear cells. J. Mass Spectrom. 38:879-890.
3. Bonora, S., M. Boffito, A. D'Avolio, M. Sciandra, A. M. Caci, F. Conta, A. Sinicco, F. G. De Rosa, and G. Di Perri. 2004. Detection of stavudine concentrations in plasma of HIV-infected patients taking zidovudine. AIDS 18:577-578.
4. Fung, E. N., Z. Cai, T. C. Burnette, and A. K. Sinhababu. 2001. Simultaneous determination of Ziagen and its phosphorylated metabolites by ion-pairing high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 754:285-295.
5. Kalhorn, T. F., A. G. Ren, J. T. Slattery, J. S. McCune, and J. Wang. 2005. A highly sensitive high-performance liquid chromatography-mass spectrometry method for quantification of fludarabine triphosphate in leukemic cells. J. Chromatogr. B 820:243-250.
6. Melendez, M., R. Blanco, W. Delgado, R. Garcia, J. Santana, H. Garcia, O. Rosario, and J. F. Rodriguez. 2006. Lack of evidence for in vivo transformation of zidovudine triphosphate to stavudine triphosphate in human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 50:835-840.
7. Pruvost, A., E. Negredo, H. Benech, F. Theodore, J. Puig, E. Grau, E. Garcia, J. Molto, J. Grassi, and B. Clotet. 2005. Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 49:1907-1914.
8. Qian, T., Z. Cai, and M. S. Yang. 2004. Determination of adenosine nucleotides in cultured cells by ion-pairing liquid chromatography-electrospray ionization mass spectrometry. Anal. Biochem. 325:77-84.
9. Salmon-Ceron, D., R. Lassalle, A. Pruvost, H. Benech, M. Bouvier-Alias, C. Payan, C. Goujard, E. Bonnet, F. Zoulim, P. Morlat, P. Sogni, S. Perusat, J. M. Treluyer, and G. Chene. 2003. Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trial. Clin. Infect. Dis. 36:1295-1304.
10. Wurtzer, S., S. Compain, H. Benech, A. J. Hance, and F. Clavel. 2005. Effect of cell cycle arrest on the activity of nucleoside analogues against human immunodeficiency virus type 1. J. Virol. 79:14815-14821.